SARS-CoV-2 virus

COVID-19 Clinical Trails

This ponder may be a randomized, double-blinded, multi-center, placebo-controlled stage III clinical trial in grown-ups matured 18~59 years. The reason of this considers is to assess the viability, security and immunogenicity of the test SARS-CoV-2 inactivated immunization. The exploratory antibody and fake treatment were both fabricated by Sinovac Inquire about & Improvement Co., Ltd. A total of 13.000 subjects will be enlisted. Member will be doled out to get two measurements of test immunization or fake treatment on the plan of day 0,14. It is arranged that the study will be conducted with two isolated cohorts. The primary cohort will be healthcare laborers within the tall chance bunch (K-1) and the moment cohort will be individuals at ordinary hazard (K-2). After 2 dosages of vaccination of 1300 volunteers are completed, security information will be assessed by the information security checking board without breaking the blinding, and in the event that there's no security issue, the K2 cohort will proceed to be vaccinated.1.300 volunteers.